Related Experiment Video
Updated: Dec 7, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Dietary interventions and cognition of Alzheimer's disease patients: a systematic review of randomized controlled
Sophia Camargos Moreira1, Ann Kristine Jansen1, Flávia Moraes Silva2
1Universidade Federal de Minas Gerais, Ringgold Standard Institution - Belo Horizonte, MG, Brazil.
Abstract:
It is estimated that by 2030 there will be 82 million people in the world with dementia.
Objective:
To evaluate the effect of dietary interventions on the cognitive performance of individuals with Alzheimer's disease (AD).
Methods:
A systematic review of randomized controlled trials (RCT) was conducted in the Scopus, PubMed, and Cochrane databases. Thirty-two RCT were included.
Results:
Omega-3 fatty acid showed positive effects at different doses. Fortasyn Connect seemed to be effective in the early stages of the disease. Probiotic, Ginseng, Inositol and specialized nutritional formulas seemed to have a positive effect on cognition. Most of the primary studies presented poor methodological quality, included patients with mild AD, small samples, and did not obtain significative results for all the cognitive outcomes.
Conclusions:
The effect of most dietary interventions on cognition in AD patients remains inconclusive, however, several nutrients, isolated or not, show potential to improve cognitive function in AD, especially in its early stages.
More Related Videos
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Dementia
The progression of dementia is generally gradual....
Atherosclerosis III: Management
Cognitive Development During Adulthood